Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers

Condition:   Multiple SclerosisInterventions:   Drug: peginterferon beta-1a;   Drug: RebifSponsor:   Biogen IdecRecruiting - verified November 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avonex | Rebif | Research | Study